Dott.ssa Stefania Salustri
Responsabile Comunicazione e Media, Web Director 06.4546891 06.45468917 cell. 348 3859419
e-mail: stefania.salustri@aspeninstitute.it sito web: www.aspeninstitute.it
Dott.ssa Paola Fienga
Assistente Comunicazione e Media
06.4546891 06.45468930 cell. 348 0731549 e-mail: paola.fienga@aspeninstitute.it
NOTA PER LA STAMPA
Aspen per il G8: la lotta alle emergenze sanitarie
Roma, 13 febbraio 2009 – Aspen Institute Italia organizza oggi a Roma in collaborazione con l’Health Policy Institute, Japan, la conferenza internazionale “Global Health Forum”.
L’incontro si tiene presso l’Hotel St. Regis Grand, via Vittorio Emanuele Orlando 3 e fa parte di in un più ampio progetto Aspen for the G8, dedicato alla presidenza italiana del G8, che intende contribuire a definire le linee guida per un’azione del G8 contrassegnata dalla sinergia tra settore pubblico e privato. La conferenza affronterà i temi cruciali della “sfida sanitaria” a livello globale, quali la lotta alle maggiori epidemie, le priorità attuali e il rafforzamento dei sistemi sanitari.
Particolare attenzione sarà dedicata ai meccanismi finanziari per sostenere una sanità diversa, che privilegi ricerca e innovazione.
La conferenza si svolge a porte chiuse. Obiettivi e risultati del dibattito saranno resi noti in una Conferenza stampa presso l’Hotel St.Regis, venerdì 13 febbraio alle ore 14:45. Al di fuori degli orari dei lavori sono possibili, previa comunicazione all’Ufficio Stampa, interviste e briefing con i singoli partecipanti.
Partecipano tra gli altri Giulio Tremonti, Ministro dell’Economia, Presidente di Aspen Institute Italia; Murray Aitken, Senior Vice President, Healthcare Insight, IMS International, Norwalk; Luca Benatti, Chief Executive Officer, Founder, Newron Pharmaceuticals, Milan; Nicola Braggio, Chairman, AstraZeneca, Milan; Franco Carraro, President, Mediocredito Centrale, Rome; Andrew Cassels, Director of Strategy, Office of the Director General, World Health Organization, Geneva;
Claudio Cavazza, Chairman, Sigma Tau, Rome; Margaret Chan, Director General, World Health Organization, Geneva; Daniela Colombo, President, AIDOS, Rome; Luca De Fraia, Director Department Advocay and Partnership, Actionaid, Milan; Luigi De Vecchi, Chief Executive Officer Italia, Credit Suisse, Milan Luigi De Vecchis, Managing Director, Nokia Siemens Networks, Milan;
Sergio Dompè, President, Farmindustria, Chairman, Dompè Farmaceutici, Rome; Philippe Douste-Blazy, UN Secretary-General’s Special Envoy on Innovative Finacing, United Nations Headquarters, New York; Andrea Federico, Partner & Market Manager Italy, Oliver Wyman, Milan; Paolo Garonna, Deputy Executive Secretary, United Nations Economic Commission for Europe, Geneva; Alicia Greenidge, Director General, IFPMA - International Federation of
Pharmaceutical Manifacturers and Associations, Geneva; William Haseltine, President, Haseltine Associates, Washington; Nicolaus Henke, Director and Head London Health Care Practice, McKinsey & Company, San Francisco; Richard Horton, Editor Chief, The Lancet, London; Sumie Ishii, Executive Director, Joicfp – Japanese Organization for international Cooperation in Family Planning, Tokio; Michel Kazatchkine, Executive Director, The Global Fund against AIDS,
Tubercolosis and Malaria, Geneva; Michael Keating, Director, APP – Africa Progress Panel, Geneva; Masaakira James Kondo, Vice Chairman, Health Policy Institute, Japan, Tokio; Kiyoshi Kurokawa, Chairman, Health Policy Institute, Japan, Tokio; William Looney, Senior Director, International Policy, Pfizer Inc.; Josh Lozman, Deputy Global Policy Manager, ONE, Washington Ignazio Roberto Marino, Senator, Rome; Giampiero Massolo, Secretary General, Minister of Foreign Affairs, Rome; Federico Nazzari, Past President, Farmindustria; Member of the Board of Directors, Recordati, Milan; Mark Never, Managing Director, Novartis Farma, Origgio; Ariel Pablos-Mendez, Managing Director, The Rockfeller Foundation, New York; Fabio Pammolli, Professor of Economics and Management, University of Florence; Director, IMT Alti Studi Lucca, Lucca; Angelos Papadimitriou, Chairman and Managing Director, GlaxoSmitKline, Verona; José Luis Roman, Chairman and Managing Director, Merck Sharp & Dohme Italia; Mubashar Sheikh, Executive Director, Global Health Workforce Alliance, Geneva; Kenji Shibuya, Professor,
Deapartment of International Health Policy and Planning, Graduate School of Medicine, Tokio University, Tokio; Fernando Silori, Chairman, Cofisan Group, Rome; Peter Singer, Director, McLaughlin-Rotman Centre for Global Health, Toronto; Keizo Takemi, Research Fellow, Harvard School of Public Health, Boston; Beatrice Trussardi, President, Fondazione Trussardi, Milan;
Rajeev Venkayya, Director, Global Health Delivery, Bill & Melinda Gates Foundation, Seattle;
Umberto Veronesi, Senator, Scientific Director, European Institute of Oncology, Milan; Charles W.
Wessner, Director, Technology, Innovation & Entrepreneurship, National Academy of Sciences, Washington; Holly Wong, Acting Vice President, Public Policy, IAVI - International AIDS Vaccine Initiative, New York.
